skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas

Journal Article · · Abdominal Radiology (Online)
; ;  [1];  [2];  [3]; ; ;  [1]
  1. David Geffen School of Medicine at UCLA, Department of Radiological Sciences (United States)
  2. David Geffen School of Medicine at UCLA, Department of Urology (United States)
  3. David Geffen School of Medicine at UCLA, Department of Pathology (United States)

Purpose: To evaluate the effect of size and central location of the tumor on safety and efficacy of percutaneous CEUS- and CT-guided MWA in biopsy-proven renal cell carcinomas (RCCs). Materials and methods: In this IRB-approved retrospective study, 69 biopsy-proven renal tumors in 56 patients, who underwent MWA in our institution from January 2013 to March 2017, were evaluated. Data collection included demographics, tumor characteristics, procedural protocols, and follow-up visits within 6 months post procedure. Primary outcomes were assessed by technical success (TS), local tumor progression (LTP), and complications. The Kaplan–Meier analysis was used for survival rate. Results: Overall technical success was achieved for all 69 lesions (92.8% primary TS, 100% overall). Median nephrometry score was 8 (4–11) and median tumor size was 2.5 cm (0.8–7). Five lesions which required second ablation had significantly higher median tumor size 4 cm (P = 0.039) with the same nephrometry score. Renal function remained stable with no significant change in eGFR before or after ablation. The LTP rate was 5.8%. The most recurrent tumors were clear cell (50%) followed by papillary tumors (25%). The complication rate was 5.8% with minor complications (hematoma and pain) and no major issues. There was no significant association between nephrometry score and technical success, recurrence, or complication rates. Overall and tumor-specific survival rates were 96.7% and 100% at 11.9 months. Conclusions: Image-guided MWA appears to be a safe and effective treatment regardless of nephrometry score and tumor location with high technical success, low recurrence, and complication rates.

OSTI ID:
22922992
Journal Information:
Abdominal Radiology (Online), Vol. 44, Issue 6; Other Information: Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature; Country of input: International Atomic Energy Agency (IAEA); ISSN 2366-0058
Country of Publication:
United States
Language:
English

Similar Records

Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical Outcomes
Journal Article · Mon Jul 15 00:00:00 EDT 2019 · Cardiovascular and Interventional Radiology · OSTI ID:22922992

Prospective Analysis of the Safety and Efficacy of Percutaneous Cryoablation for pT1NxMx Biopsy-Proven Renal Cell Carcinoma
Journal Article · Wed Jun 15 00:00:00 EDT 2011 · Cardiovascular and Interventional Radiology · OSTI ID:22922992

Microwave Ablation of Pulmonary Malignancies Using a Novel High-energy Antenna System
Journal Article · Mon Apr 15 00:00:00 EDT 2013 · Cardiovascular and Interventional Radiology · OSTI ID:22922992